Cargando…
Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms
The ability to detect SARS-CoV-2 in the upper respiratory tract ceases after 2 to 3 weeks post-symptom-onset in most patients. In contrast, SARS-CoV-2 can be detected in the stool of some patients for greater than 4 weeks, suggesting that stool may hold utility as an additional source for diagnosis....
Autores principales: | Szymczak, Wendy A., Goldstein, D. Yitzchak, Orner, Erika P., Fecher, Roger A., Yokoda, Raquel T., Skalina, Karin A., Narlieva, Momka, Gendlina, Inessa, Fox, Amy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448643/ https://www.ncbi.nlm.nih.gov/pubmed/32611796 http://dx.doi.org/10.1128/JCM.01369-20 |
Ejemplares similares
-
Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms
por: Skalina, Karin A, et al.
Publicado: (2022) -
Performance Characteristics of a High-Throughput Automated Transcription-Mediated Amplification Test for SARS-CoV-2 Detection
por: Pham, Jimmykim, et al.
Publicado: (2020) -
Detection of feline norovirus using commercial real-time RT-PCR kit for the diagnosis of human norovirus infection
por: TAKANO, Tomomi, et al.
Publicado: (2021) -
Evaluation of the FecalSwab for Stool Specimen Storage and Molecular Detection of Enteropathogens on the BD Max System
por: Richard-Greenblatt, Melissa, et al.
Publicado: (2020) -
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)